| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abbreviated course of radiotherapy (RT) for breast cancer
|
Schoenfeld, Jonathan D.
|
|
2011
|
20 |
S3 |
p. S116-S127
12 p.
|
artikel
|
| 2 |
Adjuvant chemotherapy in luminal breast cancers
|
Lim, Elgene
|
|
2011
|
20 |
S3 |
p. S128-S131
4 p.
|
artikel
|
| 3 |
Adjuvant systemic treatment for individual patients with triple negative breast cancer
|
Oakman, Catherine
|
|
2011
|
20 |
S3 |
p. S135-S141
7 p.
|
artikel
|
| 4 |
Adjuvant therapies for special types of breast cancer
|
Colleoni, Marco
|
|
2011
|
20 |
S3 |
p. S153-S157
5 p.
|
artikel
|
| 5 |
Adjuvant therapies for very young women with early stage breast cancer
|
Freedman, Rachel A.
|
|
2011
|
20 |
S3 |
p. S146-S149
4 p.
|
artikel
|
| 6 |
Beyond trastuzumab: New treatment options for HER2-positive breast cancer
|
Saini, Kamal S.
|
|
2011
|
20 |
S3 |
p. S20-S27
8 p.
|
artikel
|
| 7 |
Biological mechanisms and clinical implications of endocrine resistance in breast cancer
|
Giuliano, Mario
|
|
2011
|
20 |
S3 |
p. S42-S49
8 p.
|
artikel
|
| 8 |
Breast cancer and microRNAs: therapeutic impact
|
Iorio, Marilena V.
|
|
2011
|
20 |
S3 |
p. S63-S70
8 p.
|
artikel
|
| 9 |
Commentary on adjuvant chemotherapy for the older woman with early stage breast cancer
|
Albain, Kathy S.
|
|
2011
|
20 |
S3 |
p. S150-S152
3 p.
|
artikel
|
| 10 |
Disease related indicators for a proper choice of adjuvant treatments
|
Hayes, Daniel F.
|
|
2011
|
20 |
S3 |
p. S162-S164
3 p.
|
artikel
|
| 11 |
Editorial Board
|
|
|
2011
|
20 |
S3 |
p. iii-
1 p.
|
artikel
|
| 12 |
Immediate breast reconstruction after mastectomy
|
Veronesi, Paolo
|
|
2011
|
20 |
S3 |
p. S104-S107
4 p.
|
artikel
|
| 13 |
Immunity and autoimmunity: revising the concepts of response to breast cancer
|
Curigliano, Giuseppe
|
|
2011
|
20 |
S3 |
p. S71-S74
4 p.
|
artikel
|
| 14 |
Intraoperative radiation therapy: is it a standard now?
|
Orecchia, Roberto
|
|
2011
|
20 |
S3 |
p. S111-S115
5 p.
|
artikel
|
| 15 |
Is gene array testing to be considered routine now?
|
Paik, Soonmyung
|
|
2011
|
20 |
S3 |
p. S87-S91
5 p.
|
artikel
|
| 16 |
Is there a case for anti-HER2 therapy without chemotherapy in early breast cancer?
|
Constantinidou, Anastasia
|
|
2011
|
20 |
S3 |
p. S158-S161
4 p.
|
artikel
|
| 17 |
Lessons from the neoadjuvant setting on how best to choose adjuvant therapies
|
von Minckwitz, Gunter
|
|
2011
|
20 |
S3 |
p. S142-S145
4 p.
|
artikel
|
| 18 |
Local therapy for breast cancer in malignant lymphoma survivors
|
Intra, Mattia
|
|
2011
|
20 |
S3 |
p. S99-S103
5 p.
|
artikel
|
| 19 |
Modeling the impact of population screening on breast cancer mortality in the United States
|
Mandelblatt, Jeanne S.
|
|
2011
|
20 |
S3 |
p. S75-S81
7 p.
|
artikel
|
| 20 |
Obesity and insulin resistance in breast cancer – Chemoprevention strategies with a focus on metformin
|
Goodwin, Pamela J.
|
|
2011
|
20 |
S3 |
p. S31-S35
5 p.
|
artikel
|
| 21 |
Oncoplastic principles in breast conserving surgery
|
Urban, Cicero
|
|
2011
|
20 |
S3 |
p. S92-S95
4 p.
|
artikel
|
| 22 |
PARP inhibitors – current status and the walk towards early breast cancer
|
Glendenning, Jennifer
|
|
2011
|
20 |
S3 |
p. S12-S19
8 p.
|
artikel
|
| 23 |
Pathological work up of the primary tumor: Getting the proper information out of it
|
Viale, Giuseppe
|
|
2011
|
20 |
S3 |
p. S82-S86
5 p.
|
artikel
|
| 24 |
Patients with anti-HER2 responsive disease: definition and adjuvant therapies
|
Burstein, Harold J.
|
|
2011
|
20 |
S3 |
p. S132-S134
3 p.
|
artikel
|
| 25 |
Positive axillary sentinel lymph node: Is axillary dissection always necessary?
|
Galimberti, Viviana
|
|
2011
|
20 |
S3 |
p. S96-S98
3 p.
|
artikel
|
| 26 |
Predicting response to cytotoxic drugs – the endocrine part of the story
|
Sheri, Amna
|
|
2011
|
20 |
S3 |
p. S28-S30
3 p.
|
artikel
|
| 27 |
Prophylactic mastectomy of the contralateral breast
|
Morrow, Monica
|
|
2011
|
20 |
S3 |
p. S108-S110
3 p.
|
artikel
|
| 28 |
Reappraising antiangiogenic therapy for breast cancer
|
Kerbel, Robert S.
|
|
2011
|
20 |
S3 |
p. S56-S60
5 p.
|
artikel
|
| 29 |
Response to anti-angiogenesis: An ever changing feature
|
Bertolini, Francesco
|
|
2011
|
20 |
S3 |
p. S61-S62
2 p.
|
artikel
|
| 30 |
The science behind vitamins and natural compounds for breast cancer prevention. Getting the most prevention out of it
|
Lazzeroni, Matteo
|
|
2011
|
20 |
S3 |
p. S36-S41
6 p.
|
artikel
|
| 31 |
The St. Gallen Prize Lecture 2011: Evolution of long-term adjuvant anti-hormone therapy: consequences and opportunities
|
Jordan, V. Craig
|
|
2011
|
20 |
S3 |
p. S1-S11
11 p.
|
artikel
|
| 32 |
Tumor-stroma interactions a trademark for metastasis
|
Morales, Monica
|
|
2011
|
20 |
S3 |
p. S50-S55
6 p.
|
artikel
|
Tijdschrift beschrijving